ZIMMER BIOMET HOLDINGS, INC. - Common Stock (ZBH)

CUSIP: 98956P102

Q1 2026 13F Holders as of 31 Mar 2026

Holder snapshot 7 signals
Share change
-6,498,726
Put/Call ratio
114%
SEC-reported price per share
$90.42
Number of holders
914
Value change
-$585,591,051
Number of buys
390
Open additional details 1 more signal available
Number of sells
411
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
192,997,880

Security key

98956P102

Report period

Q1 2026

Institutions

914

Top holders

10

Ownership snapshot

Top reported holders of ZBH - ZIMMER BIOMET HOLDINGS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
DODGE & COX
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 13F 3/4/5 Lead comparable stake: 7.8% 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 7.8%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 5
BlackRock, Inc. 7.8%
VANGUARD CAPITAL MANAGEMENT LLC 7.5%
HARRIS ASSOCIATES L P 6.2%
PRICE T ROWE ASSOCIATES INC /MD/ 4.1%
Ivan Tornos 0.04%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
7.8%
$1,580,678,480
15,573,187 shares
$0 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC
13D/G
Vanguard Capital Management
7.5%
$1,335,279,791
14,767,527 shares
$0 31 Mar 2026
HARRIS ASSOCIATES L P
13D/G 13F
Company
6.2%
$1,102,842,094
12,264,703 shares
$0 31 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/
13F 13D/G
Company · T. Rowe Price Associates, Inc.
4.1%
from 13D/G
$1,225,774,000
13,631,819 shares
31 Dec 2025
Ivan Tornos
3/4/5
Chairman, President and CEO, Director
0.04%
$8,994,821
83,191 shares
mixed-class rows
06 Mar 2026
Suketu Upadhyay
3/4/5
Exec VP, CFO
0.04%
$7,085,256
69,485 shares
mixed-class rows
06 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
914
Shares
192,191,093
Rows available
914
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q1 2026 Across Filers

Q1 2026 holders
914
Q1 2026 holders
914
Holder diff
0
Investor Q1 2026 Shares Q1 2026 Shares Share Diff Share Chg % Q1 2026 value Q1 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .